Press release from Companies: Årsredovisning Aptahem AB för perioden 2021-01-01—2021-12-31

Press release from Companies: BioStock Studio: Aptahem om kommande fas I-studie

Press release from Companies: Idag inleds nyttjandeperioden för teckningsoptioner serie TO 7

Press release from Companies: Teckningskurs och information om teckningsoptioner serie TO 7

Press release from Companies: BioStock-artikel: Aptahem om den senaste nyhetsskörden

Press release from Companies: Aptahem reports prepared GMP certified Apta-1 for preparation of clinical studies

Press release from Companies: Aptahem meddelar färdigställd GMP-certifierad Apta-1 inför kliniska prövningar

Press release from Companies: Aptahem nyhetsbrev mars 2022

Press release from Companies: Aptahem reports additional positive biological effect in a Corona virus-induced acute lung injury model treated with Apta-1

Press release from Companies: Aptahem meddelar ytterligare positiva biologiska effekter i en coronavirus-orsakad lungskademodell med behandling av Apta-1

Press release from Companies: Analyst Group har publicerat analys av Aptahem och videointervju med VD Mikael Lindstam

Press release from Companies: Aptahem receives patent protection in Japan for patent family 2